Symptom-centric view
Dyspepsia
Substances reporting Dyspepsia disproportionately — ranked by ROR.
showing 5 of 5
| Substance ↓ | ROR [95% CI] | Reports | Category | Label |
|---|---|---|---|---|
tirzepatide Mounjaro · Zepbound | 3.5 [3.3–3.6] | 2,208 | glp-1 | new |
semaglutide Ozempic · Wegovy | 4.8 [4.6–5.0] | 1,789 | glp-1 | new |
nicotinamide Niacinamide | 43.6 [39.2–48.5] | 407 | longevity | new |
| 2.4 [2.1–2.8] | 237 | algemeen | new | |
| 2.8 [2.4–3.2] | 214 | algemeen | new |
ROR = reporting odds ratio vs. the full FAERS corpus. A signal is not a cause. Source: openFDA (FAERS).